Literature DB >> 26359952

Lung Clearance Index and Structural Lung Disease on Computed Tomography in Early Cystic Fibrosis.

Kathryn A Ramsey1,2, Tim Rosenow1,3, Lidija Turkovic1, Billy Skoric4,5, Georgia Banton1, Anne-Marie Adams4,5, Shannon J Simpson1, Conor Murray6, Sarath C Ranganathan4,5,7, Stephen M Stick1,8, Graham L Hall1.   

Abstract

RATIONALE: The lung clearance index is a measure of ventilation distribution derived from the multiple-breath washout technique. It has been suggested as a surrogate for chest computed tomography to detect structural lung abnormalities in individuals with cystic fibrosis (CF); however, the associations between lung clearance index and early structural lung disease are unclear.
OBJECTIVES: We assessed the ability of the lung clearance index to reflect structural lung disease on the basis of chest computed tomography across the entire pediatric age range.
METHODS: Lung clearance index was assessed in 42 infants (ages 0-2 yr), 39 preschool children (ages 3-6 yr), and 38 school-age children (7-16 yr) with CF before chest computed tomography and in 72 healthy control subjects. Scans were evaluated for CF-related structural lung disease using the Perth-Rotterdam Annotated Grid Morphometric Analysis for Cystic Fibrosis quantitative outcome measure.
MEASUREMENTS AND MAIN RESULTS: In infants with CF, lung clearance index is insensitive to structural disease (κ = -0.03 [95% confidence interval, -0.05 to 0.16]). In preschool children with CF, lung clearance index correlates with total disease extent. In school-age children, lung clearance index correlates with extent of total disease, bronchiectasis, and air trapping. In preschool and school-age children, lung clearance index has a good positive predictive value (83-86%) but a poor negative predictive value (50-55%) to detect the presence of bronchiectasis.
CONCLUSIONS: These data suggest that lung clearance index may be a useful surveillance tool to monitor structural lung disease in preschool and school-age children with CF. However, lung clearance index cannot replace chest computed tomography to screen for bronchiectasis in this population.

Entities:  

Keywords:  child; cystic fibrosis; imaging; infant; multiple-breath washout

Mesh:

Year:  2016        PMID: 26359952     DOI: 10.1164/rccm.201507-1409OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  28 in total

Review 1.  Chest imaging in cystic fibrosis studies: What counts, and can be counted?

Authors:  Rhonda Szczesniak; Lidija Turkovic; Eleni-Rosalina Andrinopoulou; Harm A W M Tiddens
Journal:  J Cyst Fibros       Date:  2016-12-28       Impact factor: 5.482

2.  Abnormal Lung Clearance Index in Cystic Fibrosis Children with Normal FEV1 and Single-Breath Nitrogen Washout Test.

Authors:  Ajay S Kasi; Choo Phei Wee; Thomas G Keens; Danieli B Salinas
Journal:  Lung       Date:  2021-01-03       Impact factor: 2.584

Review 3.  Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?

Authors:  Sarath C Ranganathan; Graham L Hall; Peter D Sly; Stephen M Stick; Tonia A Douglas
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

4.  Quantitative chest computerized tomography and FEV1 equally identify pulmonary exacerbation risk in children with cystic fibrosis.

Authors:  Don B Sanders; Zhanhai Li; Katelyn Parker-McGill; Philip Farrell; Alan S Brody
Journal:  Pediatr Pulmonol       Date:  2018-08-29

5.  Lung Clearance Index and Quantitative Computed Tomography of Post-Infectious Bronchiolitis Obliterans in Infants.

Authors:  Yoon Hee Kim; Hyun Joo Shin; In Suk Sol; Soo Yeon Kim; Jong Deok Kim; Haesung Yoon; Kyung Won Kim; Myung-Joon Kim; Mi-Jung Lee; Myung Hyun Sohn
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

6.  Lung inflammation and simulated airway resistance in infants with cystic fibrosis.

Authors:  Emily M DeBoer; Julia S Kimbell; Kaci Pickett; Joseph E Hatch; Kathryn Akers; John Brinton; Graham L Hall; Louise King; Fiona Ramanauskas; Tim Rosenow; Stephen M Stick; Harm A Tiddens; Thomas W Ferkol; Sarath C Ranganathan; Stephanie D Davis
Journal:  Respir Physiol Neurobiol       Date:  2021-06-19       Impact factor: 1.931

Review 7.  Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis.

Authors:  Mirjam Stahl; Eva Steinke; Marcus A Mall
Journal:  Genes (Basel)       Date:  2021-05-25       Impact factor: 4.096

8.  Defect distribution index: A novel metric for functional lung MRI in cystic fibrosis.

Authors:  Anne Valk; Corin Willers; Kamal Shahim; Orso Pusterla; Grzegorz Bauman; Robin Sandkühler; Oliver Bieri; Florian Wyler; Philipp Latzin
Journal:  Magn Reson Med       Date:  2021-08-02       Impact factor: 3.737

9.  Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study.

Authors:  Michelle Shaw; Umer Khan; John P Clancy; Scott H Donaldson; Scott D Sagel; Steven M Rowe; Felix Ratjen
Journal:  J Cyst Fibros       Date:  2020-06-06       Impact factor: 5.527

10.  Early Lung Disease Exhibits Bacteria-Dependent and -Independent Abnormalities in Cystic Fibrosis Pigs.

Authors:  Drake C Bouzek; Mahmoud H Abou Alaiwa; Ryan J Adam; Alejandro A Pezzulo; Leah R Reznikov; Daniel P Cook; Maria I Aguilar Pescozo; Patrick Ten Eyck; Chaorong Wu; Thomas J Gross; Douglas B Hornick; Eric A Hoffman; David K Meyerholz; David A Stoltz
Journal:  Am J Respir Crit Care Med       Date:  2021-09-15       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.